91,651 XNAS Volume
XNAS 24 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Claudio Dansky Ullmann | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 174,960 | 174,960 | - | - | Stock Option (right to buy) | |
| Alex Levit | Chief Legal Officer, Corp. Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 349,900 | 349,900 | - | - | Stock Option (right to buy) | |
| Martin A. Lehr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 802,700 | 802,700 | - | - | Stock Option (right to buy) | |
| Jennifer Minai-Azary | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 371,800 | 371,800 | - | - | Stock Option (right to buy) | |
| Andy Pasternak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 20,685 | 20,685 | - | - | Stock Option (right to buy) | |
| Luke Nathaniel Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2024 | 19,315 | 19,315 | - | - | Stock Option (right to buy) | |
| Karen L. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2024 | 19,315 | 19,315 | - | - | Stock Option (right to buy) | |
| Claudio Dansky Ullmann | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 202,170 | 202,170 | - | - | Stock Option (right to buy) | |
| Philip Kantoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Jennifer Evans Stacey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Richard J. Berman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Linda West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Alex Levit | Chief Legal Officer, Corp. Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 153,515 | 153,515 | - | - | Stock Option (right to buy) | |
| Minai-Azary Jennifer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 160,115 | 160,115 | - | - | Stock Option (right to buy) | |
| Martin Lehr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 291,402 | 291,402 | - | - | Stock Option (right to buy) | |
| Linda West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Richard J. Berman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Jennifer Evans Stacey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Philip Kantoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 21 Feb 2023 | 5,823 | 159,701 | - | 0.8 | 4,900 | Common Stock |
| Alex Levit | Chief Legal Officer, Corp. Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 151,505 | 151,505 | - | - | Stock Option (right to buy) | |
| Jennifer Minai-Azary | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 158,001 | 158,001 | - | - | Stock Option (right to buy) | |
| Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 13 Feb 2023 | 5,606 | 153,878 | - | 0.9 | 4,901 | Common Stock |
| Martin Lehr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 287,544 | 287,544 | - | - | Stock Option (right to buy) | |
| Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 06 Feb 2023 | 5,040 | 148,272 | - | 1.0 | 4,900 | Common Stock |
| Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.70 per share. | 30 Jan 2023 | 7,027 | 143,232 | - | 0.7 | 4,901 | Common Stock |
| Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.72 per share. | 23 Jan 2023 | 6,839 | 136,205 | - | 0.7 | 4,901 | Common Stock |
| Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.74 per share. | 17 Jan 2023 | 6,783 | 129,366 | - | 0.7 | 4,995 | Common Stock |
| Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.74 per share. | 16 Dec 2022 | 20,000 | 122,583 | - | 0.7 | 14,796 | Common Stock |
| Jennifer Minai-Azary | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.74 per share. | 16 Dec 2022 | 25,000 | 40,000 | - | 0.7 | 18,500 | Common Stock |
| Alex Levit | Chief Legal Officer, Corp. Sec | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 09 Dec 2022 | 6,000 | 9,000 | - | 0.8 | 5,095 | Common Stock |
| Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 19 Aug 2022 | 13,000 | 102,583 | - | 1.9 | 24,064 | Common Stock |
| Jennifer Minai-Azary | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.80 per share. | 17 Aug 2022 | 15,000 | 15,000 | - | 1.8 | 27,000 | Common Stock |
| Tarek Sahmoud | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.95 per share. | 16 Aug 2022 | 10,000 | 10,000 | - | 2.0 | 19,500 | Common Stock |
| Tarek Sahmoud | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Richard J. Berman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Philip Kantoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Linda West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Jennifer Evans Stacey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Jennifer Minai-Azary | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 112,470 | 112,470 | - | - | Stock Option (right to buy) | |
| Alex Levit | Chief Legal Officer, Corp. Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 107,870 | 107,870 | - | - | Stock Option (right to buy) | |
| Martin Lehr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 254,300 | 254,300 | - | - | Stock Option (right to buy) | |
| Evan G. Dick | Former Section 16 officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 29,223 | 29,223 | - | - | Stock Option (right to buy) | |
| William F. Rencher | Former Section 16 officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.22 per share. | 16 Dec 2021 | 13,000 | 820,190 | - | 3.2 | 41,850 | Common Stock |
| Jennifer Minai-Azary | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2021 | 52,753 | 52,753 | - | - | Stock Option (right to buy) | |
| Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 210,715 | 210,715 | - | - | Common Stock | ||
| Evan G. Dick | SVP of R&D | 22 Oct 2021 | 26,587 | 0 | - | - | Series Seed Preferred Stock | ||
| Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 586,476 | 849,878 | - | - | Common Stock | ||
| Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 22 Oct 2021 | 10,000 | 99,583 | - | 5 | 50,000 | Common Stock |
| Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 52,680 | 52,680 | - | 7.1 | 376,135 | Common Stock | |
| Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 210,722 | 263,402 | - | - | Common Stock | ||
| Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 52,680 | 0 | - | - | Warrant (right to buy) | ||
| Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 210,722 | 0 | - | - | Series A Preferred Stock | ||
| Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 586,476 | 0 | - | - | Series Seed Preferred Stock | ||
| Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 52,680 | 0 | - | 7.1 | 376,135 | Common Stock | |
| Evan G. Dick | SVP of R&D | 22 Oct 2021 | 26,587 | 87,139 | - | - | Common Stock | ||
| Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 586,475 | 797,190 | - | - | Common Stock | ||
| Martin Lehr | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 22 Oct 2021 | 10,000 | 807,190 | - | 5 | 50,000 | Common Stock |
| Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 52,680 | 0 | - | - | Warrant (right to buy) | ||
| Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 210,715 | 7 | - | - | Series A Preferred Stock | ||
| Martin Lehr | Director, Chief Executive Officer | 22 Oct 2021 | 586,475 | 1 | - | - | Series Seed Preferred Stock | ||
| Alex Levit | Chief Legal Officer, Corp. Sec | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 22 Oct 2021 | 3,000 | 3,000 | - | 5 | 15,000 | Common Stock |
| Evan G. Dick | SVP of R&D | 22 Oct 2021 | 26,587 | 0 | - | - | Series Seed Preferred Stock | ||
| Evan G. Dick | SVP of R&D | 22 Oct 2021 | 26,587 | 82,960 | - | - | Common Stock |